Where We Are Headed - New Outlook on Forest Laboratories, Inc. and Teva Pharmaceutical Industries Limited
September 26 2012 - 9:46AM
Marketwired
Moments ago, NationalTradersAssociation.org introduced new coverage
of Forest Laboratories, Inc. (NYSE: FRX) and Teva Pharmaceutical
Industries Limited (NYSE: TEVA). Full outlook, analysis and
consensus opinion is available to readers via the links below.
www.NationalTradersAssociation.org/r/gov/1e1e_FRX
www.NationalTradersAssociation.org/r/gov/42ce_TEVA
The consistent delivery of accurate analyses relies solely on
two factors, namely: market awareness and industry insight. Recent
market drivers include August's existing home sales increasing more
than expected within the U.S., a surprise slip in U.S. initial
jobless claims in the week ending September 15, 2012 and the spark
of U.S. housing starts over the last month. When it comes to
discovering the right edge at the right time, all these factors
play into effect. For a deeper understanding of the mechanics
behind these events and how it can affect your portfolio, please
refer to our email newsletter delivered to your inbox.
National Traders Association is releasing new coverage on Forest
Laboratories, Inc. for its current position within the consumer
durables sector. Forest Laboratories, Inc. (Forest) develops,
manufactures and sells branded forms of ethical drug products, most
of which requires a physician's prescription. The Company also
focuses on the development and introduction of new products,
including products developed in collaboration with licensing
partners. A copy of this report featuring Forest Laboratories, Inc.
(NYSE: FRX) is available at:
www.NationalTradersAssociation.org/r/gov/1e1e_FRX.
National Traders Association has released research on Teva
Pharmaceutical Industries Limited for its changing role within the
consumer durables sector. Teva Pharmaceutical Industries Ltd (Teva)
is a global pharmaceutical and drug company. It develops, produces
and markets generic drugs in all treatment categories. The Company
has a pharmaceutical business, whose principal products include
Copaxone and Azilect. To access the full research report on Teva
Pharmaceutical Industries Limited (NYSE: TEVA) we welcome investors
to visit: www.NationalTradersAssociation.org/r/gov/42ce_TEVA.
Consider National Traders Association Tired of hearing about the
latest, greatest trade opportunity... only to realize that the ship
has long sailed? You need a strong, informative community in your
arsenal. Join the group that has been consistently identifying
momentous situations as they develop -- long before they become the
next top news on major financial networks.
Contact: Demi Lapierre
press@NationalTradersAssociation.org
www.NationalTradersAssociation.org
Forest Road Acquisition (NYSE:FRX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Forest Road Acquisition (NYSE:FRX)
Historical Stock Chart
From Jul 2023 to Jul 2024